Tag: Precision medicine

In recent decades, nutrigenomic research has revealed that individual responses to diet are not uniform, with genetic variations playing a significant role. This paves the way for a major shift in how dietary recommendations are made, moving from a generalized, population-level approach to one that is highly personalized and based on an individual's unique genetic blueprint.

Clinical studies show that around 50% of eligible chronic myeloid leukemia (CML) patients can successfully achieve Treatment-Free Remission (TFR) after stopping tyrosine kinase inhibitor (TKI) therapy. This outcome demonstrates a growing push toward reducing lifelong medication dependence in oncology.